SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alnylam Pharmaceuticals, Inc. (ALNY)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
166 29 0 ALNY
Emcee:  michael_f_murphy Type:  Unmoderated
Min  Hr  Day  Wk  Mon  Yr  3 Yr  Log
Introduction Market Data Compact
ALNY 456.04+1.4%Oct 31 9:30 AM EDT
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
166The FDA is still working despite the firings. It approved an expansion of its apA.J. Mullen-March 21
165Good results from a Phase 3 trial of Vutrisaran, an RNAi therapy against ATTR caA.J. Mullen-6/24/2024
164Alnylam Reports Updated Positive Interim Phase 1 Results for ALN-APP, in DevelopBiotechwantabe-7/17/2023
163Alnylam 2022 R&D DayBiotechwantabe-12/16/2022
162Alnylam Pharmaceuticals Files Patent Infringement Suits against Pfizer and ModerBioBait-3/17/2022
161A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOADBioBait-2/10/2022
160Promising Phase I results for an RNAI therapy for hypertension finance.yahoo.comA.J. Mullen-11/18/2021
159Alnylam to Webcast Presentation at Stifel 3rd Annual CNS Day Hopefully they givBiotechwantabe-3/31/2021
158Results for ALN-AS1, an Investigational RNAi Therapeutic Targeting AminolevuliniA.J. Mullen-9/15/2015
157News from the clinic on Liver Cancer Ph1, they say they are "...pleased.&qupgo-neil-8/1/2011
156Progress in Parkinson's Disease shown in primates... Nice to see at least pgo-neil-8/23/2010
155Note Its in this months Popular Science and talks about ALN-VSP and *suggests* tJohn McCarthy-8/15/2010
154It's a tough road for RNAi in the clinic. I think it's partly because thidos11/20/2010
153Hi idos, The market seems to be greeting ALNY with a pronounced yawn. This latThomas-1/20/2010
152Still in mice but might be a breakthrough <b>New RNA interference techniqidos312/29/2009
151<b>Alnylam 'Highly Likely' To Name TTR Amyloidosis Rx as Its Next idos-6/14/2009
150Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical PA.J. Mullen-2/12/2009
149Alnylam and Collaborators Publish New Pre-Clinical Research Demonstrating In VivA.J. Mullen-2/11/2009
148Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics <fromA.J. Mullen-2/10/2009
147Strange, I had thought Rick's camelised girlfriend was the lab tech. My mistrkrw-1/22/2009
146>>Damn those genetically engineered mice. Cured of cancer, live forever antuck-1/21/2009
145Damn those genetically engineered mice. Cured of cancer, live forever and now thrkrw11/21/2009
144New cream disables herpes virus - U.S. study WASHINGTON, Jan 21 (Reuters) - ResA.J. Mullen-1/21/2009
143Cubist and Alnylam, An Odd Partnership by: Eben Tessari January 11, 2009 | aboutA.J. Mullen11/12/2009
142Alnylam and Cubist Form Strategic Collaboration to Develop and Commercialize RNAA.J. Mullen-1/9/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News